A recent study highlights a groundbreaking method for cancer detection that combines artificial intelligence (AI) with the olfactory abilities of dogs. Published in Scientific Reports, the research reveals that this innovative duo can identify four types of cancer in 94% of cases, including early-stage cancers.
SpotitEarly Ltd. has developed a non-invasive screening method that analyzes exhaled breath samples from patients. The technology leverages the unique molecular profiles of cancer found in breath, the dogs' ability to detect these profiles, and AI to interpret the canines' findings.
The platform demonstrates high sensitivity and specificity, making it a potential game-changer in cancer screening. Traditional methods often involve invasive procedures or exposure to ionizing radiation, leading to low compliance rates, especially in underserved areas.
This new approach may address significant under-detection issues in cancer, providing a more convenient and accessible option for early diagnosis.